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and the 3D volumes of BMEL were calculated. The signal intensity (SI)
increase of BMEL versus normal bone marrow (NBM) was calculated
as: (SIBMEL-SINBM)/SINBM×100%. Cartilage degeneration was graded
using modiﬁed Whole-Organ MRI Score (WORMS) in each compartment
as well as in cartilage overlying BMELs in the FSE images. Cartilage
was segmented semi-automatically in SPGR images. Five compartments
were deﬁned: patellar, lateral/medial femoral condyle (LFC/MFC), lat-
eral/medial tibia (LT/MT). 3D cartilage contour was overlaid to aligned
T1ø maps. T1ø values were calculated from each deﬁned compartments,
as well as from cartilage overlying BMEL. A Student’s t-test was used
to compare the overall cartilage T1ø values between patients with and
without BMEL. A paired t-test was used to compare the T1ø and clinical
grading between BMEL-overlying cartilage and surrounding cartilage, re-
spectively. The Pearson correlation coefﬁcients were calculated between
BMEL-overlying cartilage T1ø and BMEL volume, and between BMEL-
overlying cartilage T1ø and BMEL SI increase, respectively.
Results: Twenty-ﬁve BMELs were found in 16 patients (volume
2.88±3.21 cm3; SI increase 265%±110%): 11 in patella, 8 in LFC, 3 in
MFC, 2 in MT and one in LT. The overall T1ø values were signiﬁcantly
increased in patients with BMEL compared with those without BMEL
(42.5±3.8ms vs 39.6±1.1ms, P=0.012). In patients with BMEL, both
T1ø values and WORMS grading were signiﬁcantly elevated in BMEL-
overlying cartilage compared to surrounding cartilage (49.5±4.3ms vs
43.3±4.0ms, P< 0.001 for T1ø, and 4.7±1.7 vs 1.2±1.6, P< 0.001 for
WORMS grading). Increased T1ø values in BMEL-overlying cartilage were
correlated with increased SI of BMEL (R=0.54, P=0.005), but not cor-
related with BMEL volume (R=0.1, P = 0.63). No signiﬁcant differences
were found in KL and WOMAC gradings between patients with and
without BMELs in this population.
Conclusions: Patients with BMEL showed overall higher T1ø values in
cartilage compared with those who had no BMEL, suggesting BMEL may
be correlated with disease severity of OA. Furthermore, in patients with
BMEL, both T1ø values and WORMS grading were elevated in BMEL-
overlying cartilage, suggesting a local spatial correlation between BMEL
and more advanced cartilage degeneration. Interestingly, we found the
degree of T1ø elevation in BMEL-overlying cartilage is correlated with
signal intensity increase of BMEL, but not with the volume of BMEL.
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Purpose: To study the natural course of knee cartilage defects over
5 years in middle aged persons. We hypothesized that: (1) impaired mus-
cle function would predict worsening in MRI detected cartilage defects;
(2) a higher number of cartilage defects would be associated with worse
pain and function.
Methods: A prospective, population based cohort was recruited in 1990,
consisting of 183 middle-aged individuals (48% women) with chronic
knee pain (the Spenshult cohort). Inclusion criteria were: age 35−54 y
and a positive answer to the question “Have you had pain in any of
your knees on most days for the last 3 months?”. At inclusion, median
duration of knee pain was 5.5 y, 11% had a medial tibiofemoral joint
space of less than 3mm and 15% had Kellgren & Lawrence grade 2
or more when examined by standardized weight-bearing radiography.
At 3 y after inclusion, a randomly selected subgroup of 59 individuals
(mean age 50 y, 51% women) was included in a longitudinal study with
follow-ups 3 and 5 y after study inclusion. MR images were assessed
(random order, blinded for identity of the individuals and time sequence
of examinations) for cartilage defects in six different areas (medial femur,
med tibia, lateral femur, lat tibia, patella and trochlea) and graded 0−3
for each area (0 = normal cartilage, 1 = defect 50% of cartilage thickness,
3 = cartilage defect with bone attrition) yielding a possible total knee score
ranging from 0 to 18. Muscle function, measured as maximum number of
one leg rises from a 48 cm high stool, was determined at inclusion, i.e.
3 y prior to the ﬁrst MRI. Self-reported pain and function was determined
by the Knee injury and Osteoarthritis Outcome Score (KOOS) 12 y after
the initial study inclusion, 4 y after the last MRI.
Results: Longitudinal MRI data were available for 46 individuals. At the
3 and 5 y MRI follow-ups 5 individuals had improved in their cartilage
structure score during at least one time period, 10 were unchanged and
a total of 31 (67%) had deteriorated at least at one time point. The
deterioration in MRI score was signiﬁcant at both the 2 y (p = 0.002) and
5 y (p<0.001) follow-ups. Of those with a worse MRI score at the 5 y
MRI, 27% had progressed within the same area, 36% had developed
cartilage defects in previously not affected areas, and 27% had a mixed
picture with progression in previously affected areas combined with newly
affected areas as compared to the initial MRI.
Better muscle function at inclusion was associated with a lower number
of cartilage defects 5 y later (r = −0.314, p = 0.038). More severe cartilage
defects on MRI at any time point predicted worse pain, function in daily
life and in sports and recreation, knee related QoL and other symptoms
as measured by the KOOS at the 12 y follow-up, 4 y after the latest MRI
examination (p< 0.001 or better for all examinations).
Conclusions: An overall signiﬁcant worsening occurred in MRI detected
cartilage defects during a 5 year period in this population based prospec-
tive study of middle aged individuals with chronic knee pain. Good
functional performance seemed to be protective against worsening of
cartilage damage. More severe cartilage damage was associated with a
worse long-term clinical outcome as measured by KOOS.
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Purpose: Bone Marrow Lesions (BML) have been noted as a risk factor
for progression of tibiofemoral osteoarthritis (OA). Previous work has
shown that size and location of BML in a compartment is associated
with adjacent cartilage damage. No study however has examined the
relationship between the proximity of the BML to the chondral plate
(depth) and cartilage loss. Assuming BML represent a focus of active
remodeling and potentially necrosis, their ability to impact bone-cartilage
interactions may be mediated by their depth. We utilized data from the
Osteoarthritis Initiative study (OAI), to explore whether depth of BML is a
contributing factor to cartilage loss along with BML size.
Methods: The OAI progression subcohort is a subset of the approxi-
mately 4700 subjects in OAI, a multicenter observational study of subjects
with or at risk for knee OA, (Public use dataset 0.1.1, 0.B.1, 0.B.2). Each
subject had a 3T MRI (Siemens Trio) done at baseline and 12 month
follow-up. Using 3D DESSwe MR images and a segmentation algorithm
developed by VirtualScopics, cartilage volume (normalized by area) and
denuded area were computed. MRIs were also scored using the Boston-
Leeds Osteoarthritis Knee Score (BLOKS), a semi-quantitative scoring
method which has been validated. The BLOKS measure included grading
from 0−3 of BML size and percent of BML adjacent to chondral plate (see
ﬁgure). We categorized BML by size (size score 2 vs. 3) and depth (%
adjacent to plate score 2 vs. 3) and then created a composite variable
consisting of both size and depth. One knee was selected for analysis
and was a subset of all subjects who had MRI performed at baseline
and 12 month follow-up. We used linear regression to generate the mean
change in normalized volume and denuded area in the adjacent chondral
plate for each category of BML while controlling for age, BMI and gender.
Adjusted means were compared between the four BML groups using
Tukey’s method.
Results: The 150 subjects in this analysis had a mean age of 60.9 years
and a mean BMI of 30.3 kg/m2. With respect to the central medial tibia
(CMT), the increase in denuded area is greatest when large and distant
lesions were present, compared to the presence of small and close and
small and distant lesions (35.5mm vs. 0.29mm and −2.9mm, p< 0.05)
(see table). With respect to the central medial femur (CMF), the same
pattern is present. Large and distant BML were associated with greater
increase in denuded area compared to small and close and small and
distant BML (64.3mm2 vs. 6.5mm2 and 4.6mm2, p< 0.05). There were
no signiﬁcant differences in change in normalized volume among the four
groups in the CMT or CMF. There were insufﬁcient numbers of subjects
with large and close lesions to permit comparisons.
Conclusions: Size and depth of BML are associated with increased
cartilage loss. Lesions that were large and distant were associated
with greater cartilage loss than small lesions of any depth. Although
not reaching statistical signiﬁcance, there is a trend which indicates
a combined effect of size and depth in the amount of cartilage loss.
Further analyses looking at BML depth are needed. Scoring systems
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which include BML depth as well as size may be more valid than scoring
systems not including BML depth.
Figure 1. Diagram of BML scoring system (tibia).
Table 1: Comparison of mean change in cartilage parameters by BML category
CMT CMF
n volume
normalized
(mm, 95%CI)
denuded area
(mm2, 95%CI)
n volume
normalized
(mm, 95%CI)
denuded area
(mm2, 95%CI)
Large and distant 43 −0.06
(−0.1, −0.02)
35.5
(17.7, 53.3)
27 −0.10
(−0.2, 0.02)
64.25
(32.0, 96.5)
Large and close 9 −0.05
(−0.1, 0.03)
12.2
(−26.3, 50.8)
4 0.03
(−0.2, 0.2)
−29.00
(−112.8, 54.9)
Small and distant 34 0.02
(−0.03, 0.1)
−2.94*
(−22.7, 16.8)
43 −0.05
(−0.1, 0.01)
4.56*
(−21.0, 30.2)
Small and close 64 0.01
(−0.02, 0.03)
0.29*
(−14.2, 14.8)
76 −0.02
(−0.1, 0.03)
6.50*
(−12.8, 25.8)
*p< 0.05 compared to large and distant after controlling for age, gender and BMI. CMT=central
medial tibia; CMF=central medial femur.
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Purpose: The aim of this study is to investigate whether cartilage thick-
ness, measured from MR, is comparable between 3 different vendors’
3T scanners. The ability to use different centres/vendors’ scanners would
facilitate patient recruitment and data acquisition in studies of Osteoarthri-
tis (OA). The NIH OA Initiative uses Siemens scanners, but both Philips
Medical Systems and GE Healthcare also manufacture 3T scanners.
Methods: 12 subjects with knee symptoms of OA and one or more risk
factors had their symptomatic knee scanned on each of the 3 vendor’s
scanners. Mean age 49.3±10 years (range 32−59 y); mean BMI 28.3±6.2
(range 22.1−44.2). The MR systems are located in three sites in the UK:
Manchester (Philips), York (GE), Liverpool (Siemens). The NIH OAI study
protocol was used for the Siemens scanner and corresponding protocols
were developed for the Philips and GE scanners in collaboration with
the vendors. The RF coils used were transmit-receive (GE), receive-only
(Siemens) and 8-channel phased-array (Philips). To enable intra-scanner
analysis, following the Philips acquisition, subjects were repositioned and
the sagittal 3D sequence repeated.
Manual cartilage segmentation of the sagittal 3D sequence was per-
formed by a single observer, blinded to subject identity, using EndPoint
software (Imorphics, Manchester, UK). Subchondral bone was auto-
matically segmented using a statistical appearance model to deﬁne a
reference bone shape in each image which provided a dense set of
60,456 and 39,238 anatomically corresponding points on the subchondral
bone surfaces of the distal femur and proximal tibia respectively. Cartilage
thickness was measured above each corresponding point and mean
thickness (ThCtAB) was computed within anatomical trimmed regions,
also deﬁned using the correspondences.
Results: The ﬁgure shows intra-scanner (Philips) and inter-scanner
agreement for all scanner pairs for ThCtAB within the trimmed central
medial femur (cMF) region and demonstrates small systematic differ-
ences. The intra-scanner mean difference was 0.03mm. Inter-scanner
mean differences ranged from 0.05mm to 0.2mm. The table shows the
intra-scanner and inter-scanner root mean square coefﬁcient of variation
(RMS CoV) for the ThCtAB measure for a selection of regions. These
range from 2.4%-4.6% (intra-scanner) and 4.2% to 7.7% (inter-scanner).
Figure 1. Bland and Altman plot demonstrating intra-scanner and in-
terscanner agreement. P1=Philips 1st scan, P2=Philips 2nd scan,
S=Siemens, G=GE.
ThCtAB: RMS COVs. (c)MF/T= (central) medial femur/tibia, (c)LF/T= (central) lateral femur/tibia
Region RMS CoV (%)
Intra-scanner Inter-scanner
P G&S P&S P&G P&G&S
MF 2.77 5.15 5.81 7.31 6.11
cMF 3.21 5.62 5.41 9.61 7.16
LF 3.61 4.20 4.90 7.19 5.57
cLF 2.63 5.11 4.11 6.58 5.34
MT 4.64 7.65 5.77 5.36 6.30
LT 4.08 7.69 4.00 8.07 6.95
Conclusions: This is the ﬁrst report which compares knee cartilage
thickness measures taken from 3T MR images acquired using three
different vendors’ scanners in OA subjects. Intra-scanner precision errors
are in line with other studies. Systematic differences between vendors’
cartilage thickness results are comparable with intra-scanner variability.
Increased variability was exhibited between the Philips and GE scanners
which may be due to differences in RF coil technology or image post-
processing.
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Purpose: A rapid increase in the angiogenic invasion of the pannus
and synovial membrane caused by mechanical trauma is a critical event
necessary for the initiation of cartilage and subchondral bone destruction
in osteoarthritis (OA). However, the exact intracellular mechanisms of
angiogenic responses induced by trauma remain unclear. In this study,
we hypothesize that unbalanced mechanical forces applied to the synovial
joint can drive angiogenesis through the activation of Akt pathway via
VEGF receptors and is necessary for the development of OA.
Methods:Well characterized CD31+/vWF+ human dermal microvascular
endothelial cells (HDMEC) were grown on ﬂexible bottom Bioﬂex II
plates (Flexcell Int, NC). HDMEC were exposed to various magnitudes
(3%, 6%, 12%) and frequencies (0.25Hz, 0.1Hz, 0.05Hz) of dynamic
equibiaxial tensile strain (DTS) for different time intervals. Il-1b (2 ng/ml)
was used to mimic inﬂammatory conditions of the OA joints. Inhibitors to
various kinases were used to conﬁrm the actions of mechanical signals.
Subsequently, proteins or RNA were extracted. Activation of kinases
involved in Akt pathway were examined by Western blot analysis and
